- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
The UK is poised for a modest economic upturn due to lower energy prices, government support measures, and a robust labor market. However, trade prospects may remain lacklustre due to the sluggish economies of major trading partners. Businesses also face a high cost of financing which remains another area of concern. In line with this […]
FDA approval of subcutaneous Vyvgart tackles one of the unmet needs in myasthenia gravis indication, says GlobalData
Following the news that the FDA has approved Argenx’s subcutaneous formulation of efgartimod alfa, branded as Vyvgart Hytrulo, for use in myasthenia gravis (MG); Barbora Salcman, Neurology Analyst at GlobalData, offers her view: “The approval comes after a period of uncertainty and extends the availability of Vyvgart to acetylcholine receptor autoantibody positive (AChR+) patients diagnosed […]
VC investment in India tumbles 74.6% YoY to $3.4 billion during January-May 2023, reveals GlobalData
India’s venture capital (VC) funding landscape faced a harsh funding winter during the first five months of 2023, witnessing a substantial 46.1% year-on-year (YoY) drop in VC deals volume and a massive 74.6% decline in funding value during the period, reflecting the challenging funding environment, according to GlobalData, a leading data and analytics company. An […]
Healthcare professionals see biosimilars as solution to tackle rising costs, finds GlobalData survey
The healthcare industry continues to face the challenges such as persistent inflation in a post-COVID-19 world. Healthcare professionals (HCPs) believe that biosimilars could provide costs savings for the patients and healthcare systems and their use should be encouraged, according to a survey by GlobalData, a leading data and analytics company. GlobalData survey, “The Impact of […]
China venture capital funding sees decline, yet remains a force in global market, reveals GlobalData
The China venture capital (VC) funding landscape experienced a decline in both deal volume and value during January to May 2023 compared to the previous year, attributed to geopolitical tensions and recession concerns. However, China remains a dominant player in the Asia-Pacific (APAC) region and globally, showcasing its continued significance in VC funding activities, reveals […]
Consumer interest in health drives growth of functional mushroom ingredients across FMCG industry, reveals GlobalData
Consumer interest in functional mushrooms is rapidly surging as people recognize their potential health benefits. This trend is driving the growth of mushroom-infused products across FMCG industry, from food and beverages to dietary supplements and beauty, as consumers increasingly seek natural and affordable options to support their well-being, reveals GlobalData, a leading data and analytics […]
Malaysia SVoD household penetration to reach 41% in 2027, forecasts GlobalData
The household penetration of subscription video on demand (SVoD) services in Malaysia is expected to increase from 22% in 2022 to 41% in 2027, driven by the increasing consumer preference towards SVoD platforms as broadband services continue to improve in the country, forecasts GlobalData, a leading data and analytics company. GlobalData’s Malaysia Subscription Video on […]
VALUE-Dx initiative highlights potential for improved respiratory infection diagnostics to decelerate AMR, says GlobalData
VALUE-Dx, a first-of-its-kind Innovative Medicines Initiative (IMI) project which aims to improve the use of antibiotics in community care settings, has recently released preliminary information from its upcoming consensus statement on rapid diagnostic tests (RDT) for acute respiratory tract infections (ARTIs) at a post- European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) conference. The […]
AI advancements propel NVIDIA to elite trillion-dollar club, says GlobalData
Riding on the growing demand for generative artificial intelligence (AI) tools, US-based semiconductor giant Nvidia had briefly vaulted past the $1 trillion market capitalization mark. In the process, it has become the seventh US company to achieve this milestone, joining Microsoft, Apple, Alphabet, Amazon, Meta, and Tesla. The only non-US company in the club is […]
South Korea oncology tests market set for 2% CAGR through 2030, forecasts GlobalData
Lung cancer is one of the leading causes of cancer-related deaths in South Korea and globally. Most lung cancer patients are diagnosed at an advanced stage and often respond poorly to treatment. Therefore, there is a growing demand for new screening technologies for the early detection of lung cancer. Against this backdrop, South Korea’s oncology […]
Malaysia economy growth in 2023 to surpass last five years average, forecasts GlobalData
Malaysia’s economic growth in 2023 is predicted to be fuelled by easing inflationary pressure, a stronger job market, and solid growth in private consumption. Nevertheless, weak external demand poses a downside risk that could affect trade prospects. Against this backdrop, Malaysia’s economic growth is set to reach 4% in 2023, surpassing the average growth of […]
Medical robotic market set to witness 8% CAGR between 2022 and 2030, forecasts GlobalData
Due to higher capital expenditures, the medical robotics industry was more vulnerable to economic headwinds in 2022 than producers of less expensive devices. However, as underlying demand is still very strong, the robotics business will keep growing through 2030. Against the backdrop, the surgical robotics market is set to grow at a compound annual growth […]
Medical devices companies discussion revolve around exploring AI to deliver new diagnostics tools, says GlobalData
Artificial intelligence (AI) is a popular topic of conversation in companies’ filings with the potential to revolutionize many industries and it is not surprising that AI has generated a lot of discussion in the medical industry. The medical industry is among the top five industries which have the most discussions about AI in Q1 2023, […]
Apple Vision Pro headset sparks mixed reactions on Reddit over high price, gaming limitations, reveals GlobalData
Apple’s Vision Pro, the mixed-reality headset unveiled at the June 2023 Worldwide Developers Conference, has created a substantial buzz in the tech industry. This excitement translated into a notable increase in Reddit discussions during the second week of June. Among Redditors, there is a divergence of opinions regarding the device. While some are enamored with […]
Australia SVOD service revenue to grow at 8.2% CAGR over 2022-2027, forecasts GlobalData
The subscription video on demand (SVOD) service revenue in Australia is expected to increase at a compound annual growth rate (CAGR) of 8.2% from $1.9 billion in 2022 to $2.8 billion by 2027, driven by a healthy growth in SVOD subscriptions, and steady rise in the average monthly revenue per unique SVOD household, according to […]
VC investment in US plunges 50.2% YoY to $55.3 billion during January-May 2023, reveals GlobalData
Venture capital (VC) funding activity in the US experienced a significant decline during January to May 2023. A total of 3,532 VC funding deals of worth $55.3 billion were announced in the US during the period. This represents a year-on-year (YoY) decline of 36.4% in terms of volume announced and a massive 50.2% in terms […]
Travel and tourism industry deal activity plummets by 41% YoY in January-May 2023, reveals GlobalData
The travel and tourism industry has witnessed a massive 41% year-on-year (YoY) decline in deal activity from 475 deals announced during January-May 2022 to 282* during the first five of months of 2023, reveals GlobalData, a leading data and analytics company. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The decline in deal activity in the […]
Asia-Pacific deal activity decline by 25% YoY during January-May 2023, reveals GlobalData
The Asia-Pacific (APAC) region witnessed a 25% year-on-year (YoY) decline in deal activity during January to May 2023, in line with the global trend of economic uncertainties impacting deal activity. The decline was seen across all types of deals (mergers & acquisitions, private equity, and venture financing deals) and major markets in the region, reveals GlobalData, […]
Cetuximab biosimilars launch to improve Alkem, Lupin brand equity within oncology in India, opines GlobalData
Alkem Laboratories Ltd and Lupin Ltd have recently launched the world’s first cetuximab biosimilar in India for the treatment of head and neck cancer (HNC). With this, Alkem and Lupin are in a unique position to improve their brand equity within the oncology therapy area in India, says GlobalData, a leading data and analytics company. […]
Left ventricular assist device segment set to reach $2.24 billion in 2033, forecasts GlobalData
The prevalence of heart failure continues to rise alarmingly due to the rapidly growing aging population while there is a limited availability of hearts for transplantation. As a result, the demand for reliable ventricular assist devices is set to grow giving way to the development of more advanced products. Against this backdrop, the left ventricular […]